Some good news on the weight-loss front: Customers can now go to Costco to get Ozempic and Wegovy, brand-name injectable prescription drugs manufactured by drugmaker Novo Nordisk, which contain the same active ingredient: semaglutide.
The Danish pharmaceutical firm announced Friday that both are available at the big-box retailer’s pharmacies nationwide, for $499 for a month’s supply—the same price as sold in CVS, Walmart, and the company’s direct-to-consumer website. You’ll still need a prescription to buy the drugs.
Fast Company has reached out to both Costco and Novo Nordisk for comment.
Also—Costco is offering a 2% discount for Costco executive members and Costco Citibank Visa cardholders, according to CBS News.
The medications are similar but the Food and Drug Administration has approved them for two different reasons. Wegovy is approved for chronic weight management. Ozempic is approved for treating type 2 diabetes and to reduce the risk of cardiovascular health issues including heart attack, stroke, and death in people with type 2 diabetes and heart disease. Ozempic is prescribed “off-label” for weight loss.
They are administered in different dosages and reportedly have different side effects. Because Wegovy is administered at higher doses, a maximum of 2.4 milligrams per week, it may lead to greater weight loss but also more gastrointestinal side effects. Ozempic is typically administered at 2 milligrams per week. Each are injected once a week.
Costco financials
Costco Wholesale Corp. (COST) stock was down less than 1% during afternoon trading on October 6.
The company reported fourth-quarter earnings for the period ending August 31, 2025, with net sales for the quarter up 8% to $84.4 billion (from $78.2 billion last year). Net sales for the fiscal year increased 8.1% to $269.9 billion (from $249.6 billion last year).
Costco currently has a market capitalization of $402.6 billion.
